Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial

Marius Trøseid; JR Arribas; Lambert Assoumou; Aleksander Rygh Holten; Julien Poissy; Vida Terzić; Fulvia Mazzaferri; Jesús  Rodríguez-Baño; Joe Eustace; Maya Hites; Michael Joannidis; Jose-Artur Paiva; Jean Reuter; Isabel Püntmann; Thale Patrick-Brown; Elin Westerheim; Katerina Nezvalova-Henriksen; Lydie Beniguel; Tuva Børresdatter Dahl; Maude Bouscambert-Duchamp; Monika Halanova; Zoltan Peterfi; Sotirios Tsiodras; Michael Rezek; Matthias Briel; Serhat Unal; Martin Schlegel; Florence Ader; Karine Lacombe; Cecilie Delphin Amdal; Serge Rodrigues Serge Rodrigues; Kristian Tonby; Alexandre Gaudet; Lars Heggelund; Joy Mootien; Asgeir Johannessen; Jannicke Horjen Møller; Beatriz Diaz Pollan; Anders Tveita; Anders Benjamin Kildal; Jean-Christophe Richard; Olav Dalgard; Victoria Charlotte Simensen; Aliou Baldé; Lucie de Gastines; Marta del Álamo; Burç Aydin; Fridtjof Lund-Johansen; Mary-Anne Trabaud; Alpha Diallo; Bente Halvorsen; John-Arne Røttingen; Evelina Tacconelli; Yazdan Yadanapanah; Inge Christoffer Olsen; Dominique Costagliola

SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4172086 issn: 1556-5068

Marius Trøseid, JR Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzić, Fulvia Mazzaferri, Jesús Rodríguez-Baño, Joe Eustace, Maya Hites, Michael Joannidis, Jose-Artur Paiva, Jean Reuter, Isabel Püntmann, Thale Patrick-Brown, Elin Westerheim, Katerina Nezvalova-Henriksen, Lydie Beniguel, Tuva Børresdatter Dahl, Maude Bouscambert-Duchamp